XML 19 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue

2.        Revenue

The Company launched LOQTORZI in December 2023, YUSIMRY in July 2023 and CIMERLI in October 2022. Net revenue for sales of YUSIMRY and CIMERLI effectively ceased to be recognized in the Company’s condensed consolidated statements of operations on June 26, 2024 and March 1, 2024, respectively (see Note 6. Acquisition and Dispositions). All net product revenue was generated in the United States, and the Company’s net revenue was as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Nine Months Ended

​

​

September 30, 

​

September 30, 

(in thousands)

    

2024

​

2023

​

2024

    

2023

Products

​

​

​

​

​

​

​

​

​

​

​

​

UDENYCA

​

$

66,089

​

$

32,967

​

$

159,673

​

$

90,875

CIMERLI

​

​

(1,215)

​

​

40,037

​

​

26,979

​

​

72,939

YUSIMRY

​

​

(152)

​

​

1,360

​

​

7,508

​

​

1,360

LOQTORZI

​

​

5,832

​

​

—

​

​

11,609

​

​

—

Total net product revenue

​

​

70,554

​

​

74,364

​

​

205,769

​

​

165,174

Other revenue

​

 

220

​

 

204

​

 

7,047

​

 

546

Total net revenue

​

$

70,774

​

$

74,568

​

$

212,816

​

$

165,720

​

Gross product revenues by significant customer as a percentage of total gross product revenues were as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

Three Months Ended

​

Nine Months Ended

 

​

​

September 30, 

​

September 30, 

​

​

​

2024

 

​

2023

​

​

2024

 

​

2023

 

McKesson Corporation

 

45

%

​

44

%

​

41

%

​

38

%

Cencora (previously known as AmeriSource-Bergen Corporation)

 

33

%

​

41

%

​

39

%

​

45

%

Cardinal Health, Inc.

 

21

%

​

13

%

​

18

%

​

15

%

​

Product Sales Discounts and Allowances

The total provision related to sales made in the prior period was $0.3 million and $1.1 million for the three months ended September 30, 2024 and 2023, respectively. Chargebacks and discounts for prompt payment are recorded as a reduction in trade receivables, and the remaining reserve balances are classified as current liabilities and other liabilities, non-current on the accompanying unaudited condensed consolidated balance sheets.

In connection with the Sale Transactions, the Company retained and will continue to be responsible for sales discounts and allowance liabilities incurred prior to March 1, 2024 for CIMERLI and June 26, 2024 for YUSIMRY. Sales discounts and allowances incurred on behalf of the respective counterparties following the close of the Sale Transactions in accordance with the Company’s Transition Services Agreement with Sandoz (the “CIMERLI TSA”) in March 2024 for CIMERLI and the Company’s Transition Services Agreement with HKF (the “YUSIMRY TSA” and, together with the CIMERLI TSA, collectively the “TSA”) in June 2024 for YUSIMRY are reflected within TSA receivables, net and TSA payables and other accrued liabilities in the unaudited condensed consolidated balance sheets and are excluded from the below table (see Note 6. Acquisition and Dispositions).

The activities and ending reserve balances for each significant category of discounts and allowances that constitute variable consideration were as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nine Months Ended September 30, 2024

​

    

Chargebacks

    

​

​

    

Other Fees,

    

​

​

​

​

and Discounts

​

​

​

​

Co-pay

​

​

​

​

​

for Prompt

​

​

​

​

Assistance

​

​

​

(in thousands)

​

Payment

​

Rebates

​

and Returns

​

Total

Balances at December 31, 2023

​

$

73,953

​

$

121,137

​

$

49,795

​

$

244,885

Provision related to sales made in:

​

​

​

​

​

​

​

​

​

​

​

​

Current period

​

​

727,028

​

​

150,820

​

​

117,299

​

​

995,147

Prior period - increase (decrease)

​

​

(969)

​

​

6,343

​

​

(1,010)

​

​

4,364

Payments and customer credits issued

​

 

(747,070)

​

​

(159,737)

​

​

(121,332)

​

​

(1,028,139)

Balances at September 30, 2024

​

$

52,942

​

$

118,563

​

$

44,752

​

$

216,257

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nine Months Ended September 30, 2023

​

    

Chargebacks

    

​

​

    

Other Fees,

    

​

​

​

​

and Discounts

​

​

​

​

Co-pay

​

​

​

​

​

for Prompt

​

​

​

​

Assistance

​

​

​

(in thousands)

​

Payment

​

Rebates

​

and Returns

​

Total

Balances at December 31, 2022

​

$

42,677

​

$

38,713

​

$

19,113

​

$

100,503

Provision related to sales made in:

​

​

​

​

​

​

​

​

​

​

​

​

Current period

​

 

387,238

​

​

83,009

​

​

69,362

​

​

539,609

Prior period - increase (decrease)

​

​

(1,375)

​

​

1,540

​

​

4,469

​

​

4,634

Payments and customer credits issued

​

 

(379,076)

​

 

(42,097)

​

 

(55,681)

​

 

(476,854)

Balances at September 30, 2023

​

$

49,464

​

$

81,165

​

$

37,263

​

$

167,892

​